Marín C - Search Results

1

Long-term treatment with intermitent intranasal or subcutaneous apormorphine in patients with levodopa-related motor fluctuations.

Esteban Muñoz J, Martí MJ, Marín C, Tolosa E. Esteban Muñoz J, et al. Among authors: marin c. Clin Neuropharmacol. 1997 Jun;20(3):245-52. doi: 10.1097/00002826-199706000-00009. Clin Neuropharmacol. 1997. PMID: 9197948

2

Striatal synaptophysin levels are not indicative of dopaminergic supersensitivity.

Marin C, Tolosa E. Marin C, et al. Neuropharmacology. 1997 Aug;36(8):1115-7. doi: 10.1016/s0028-3908(97)00097-x. Neuropharmacology. 1997. PMID: 9294977

3

Glutamate receptor-mediated mechanisms in levodopa-induced motor fluctuations in an experimental model of parkinsonism.

Marin C, Tolosa E. Marin C, et al. Adv Neurol. 1999;80:129-33. Adv Neurol. 1999. PMID: 10410712 No abstract available.

4

Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease.

Cardellach F, Martí MJ, Fernández-Solá J, Marín C, Hoek JB, Tolosa E, Urbano-Márquez A. Cardellach F, et al. Among authors: marin c. Neurology. 1993 Nov;43(11):2258-62. doi: 10.1212/wnl.43.11.2258. Neurology. 1993. PMID: 8232939

5

Narrow beneficial effect of dextromethorphan on levodopa-induced motor response alterations in an experimental model of parkinsonism.

Jiménez A, Marin C, Bonastre M, Tolosa E. Jiménez A, et al. Among authors: marin c. Brain Res. 1999 Aug 21;839(1):190-3. doi: 10.1016/s0006-8993(99)01657-1. Brain Res. 1999. PMID: 10482813

6

Non-NMDA receptor-mediated mechanisms are involved in levodopa-induced motor response alterations in Parkinsonian rats.

Marin C, Jimenez A, Bonastre M, Chase TN, Tolosa E. Marin C, et al. Synapse. 2000 Jun 15;36(4):267-74. doi: 10.1002/(SICI)1098-2396(20000615)36:4<267::AID-SYN3>3.0.CO;2-Y. Synapse. 2000. PMID: 10819904

7

LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian rats.

Marin C, Jiménez A, Bonastre M, Vila M, Agid Y, Hirsch EC, Tolosa E. Marin C, et al. Synapse. 2001 Oct;42(1):40-7. doi: 10.1002/syn.1097. Synapse. 2001. PMID: 11668589

8

Adenosine A2A antagonism reverses levodopa-induced motor alterations in hemiparkinsonian rats.

Bové J, Marin C, Bonastre M, Tolosa E. Bové J, et al. Among authors: marin c. Synapse. 2002 Dec 15;46(4):251-7. doi: 10.1002/syn.10112. Synapse. 2002. PMID: 12373740

9

Effect of acute and chronic administration of U50,488, a kappa opioid receptor agonist, in 6-OHDA-lesioned rats chronically treated with levodopa.

Marin C, Bové J, Bonastre M, Tolosa E. Marin C, et al. Exp Neurol. 2003 Sep;183(1):66-73. doi: 10.1016/s0014-4886(03)00107-9. Exp Neurol. 2003. PMID: 12957489

10

Early administration of entacapone prevents levodopa-induced motor fluctuations in hemiparkinsonian rats.

Marin C, Aguilar E, Bonastre M, Tolosa E, Obeso JA. Marin C, et al. Exp Neurol. 2005 Mar;192(1):184-93. doi: 10.1016/j.expneurol.2004.10.008. Exp Neurol. 2005. PMID: 15698633

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,019 results

Search Page

Filters